Evidence map›Paper›PMID 38128058›Full record

ArticleJournal of applied clinical medical physics2024

Accurate and robust auto-segmentation of head and neck organ-at-risks based on a novel CNN fine-tuning workflow.

Shunyao Luan, Kun Wu, Yuan Wu, Benpeng Zhu, Wei Wei, Xudong Xue

Open access · goldAbstract read
In one paragraph

Article in Journal of applied clinical medical physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Artificial intelligence uncertainty quantification in radiotherapy applications - A scoping review.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2024
    Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Shunyao LuanDepartment of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Kun WuDepartment of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Yuan WuDepartment of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Benpeng ZhuSchool of Integrated Circuits, Laboratory for Optoelectronics, Huazhong University of Science and Technology, Wuhan, China.
Wei WeiDepartment of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Xudong XueDepartment of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Huazhong University of Science and Technology · CNHubei Cancer Hospital · CNWuhan National Laboratory for Optoelectronics · CN

Funding

Health Commission of Hubei Province WJ2021M192Health Commission of Hubei Province WJ2021Q046National Natural Science Foundation of China 12075095
6 · The paper itself

Abstract

purposeObvious inconsistencies in auto-segmentations exist among various AI software. In this study, we have developed a novel convolutional neural network (CNN) fine-tuning workflow to achieve precise and robust localized segmentation.

methodsThe datasets include Hubei Cancer Hospital dataset, Cetuximab Head and Neck Public Dataset, and Québec Public Dataset. Seven organs-at-risks (OARs), including brain stem, left parotid gland, esophagus, left optic nerve, optic chiasm, mandible, and pharyngeal constrictor, were selected. The auto-segmentation results from four commercial AI software were first compared with the manual delineations. Then a new multi-scale lightweight residual CNN model with an attention module (named as HN-Net) was trained and tested on 40 samples and 10 samples from Hubei Cancer Hospital, respectively. To enhance the network's accuracy and generalization ability, the fine-tuning workflow utilized an uncertainty estimation method for automatic selection of candidate samples of worthiness from Cetuximab Head and Neck Public Dataset for further training. The segmentation performances were evaluated on the Hubei Cancer Hospital dataset and/or the entire Québec Public Dataset.

resultsA maximum difference of 0.13 and 0.7 mm in average Dice value and Hausdorff distance value for the seven OARs were observed by four AI software. The proposed HN-Net achieved an average Dice value of 0.14 higher than that of the AI software, and it also outperformed other popular CNN models (HN-Net: 0.79, U-Net: 0.78, U-Net++: 0.78, U-Net-Multi-scale: 0.77, AI software: 0.65). Additionally, the HN-Net fine-tuning workflow by using the local datasets and external public datasets further improved the automatic segmentation with the average Dice value by 0.02.

conclusionThe delineations of commercial AI software need to be carefully reviewed, and localized further training is necessary for clinical practice. The proposed fine-tuning workflow could be feasibly adopted to implement an accurate and robust auto-segmentation model by using local datasets and external public datasets.

Indexed as

Image Processing, Computer-AssistedTomography, X-Ray ComputedCetuximabHumansNeural Networks, ComputerOrgans at RiskWorkflowCetuximabconvolutional neural networkfine-tuningradiotherapysegmentation

Identifiers

PMID38128058
PMCPMC10795444
OpenAlexW4390043823

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.